calima 0,02 mg/3 mg apvalkotās tabletes
sandoz d.d., slovenia - ethinylestradiolum, drospirenonum - apvalkotā tablete - 0,02 mg/3 mg
diener 0,03 mg/2 mg apvalkotās tabletes
laboratorios leon farma s.a., spain - ethinylestradiolum, dienogestum - apvalkotā tablete - 0,03 mg/2 mg
gesytil 75/20 mikrogramu apvalkotās tabletes
ratiopharm gmbh, germany - gestodenum, ethinylestradiolum - apvalkotā tablete - 75 μg/20 μg
gesytil 75/30 mikrogramu apvalkotās tabletes
ratiopharm gmbh, germany - gestodenum, ethinylestradiolum - apvalkotā tablete - 75 μg/30 μg
gracial tabletes
aspen pharma trading ltd., ireland - desogestrelum, ethinylestradiolum - tablete
orindille 0,02 mg/3 mg apvalkotās tabletes
orivas uab, lithuania - ethinylestradiolum, drospirenonum - apvalkotā tablete - 0,02 mg/3 mg
orindille 0,03 mg/3 mg apvalkotās tabletes
orivas uab, lithuania - ethinylestradiolum, drospirenonum - apvalkotā tablete - 0,03 mg/3 mg
etonogestrel/ethinylestradiol mithra 120/15 mikrogrami/24 stundās vaginālās ievadīšanas sistēma
mithra pharmaceuticals n.v., belgium - etonogestrelum, ethinylestradiolum - vaginālās ievadīšanas sistēma - 120/15 mikrogrami/24 stundās
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomioma - hipofīzes un hipotalāma hormoni un analogi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
yarina 3 mg/0,03 mg apvalkotās tabletes
bayer ag, germany - drospirenonum, ethinylestradiolum - apvalkotā tablete - 3 mg/0,03 mg